Status
Conditions
Treatments
About
The goal of this work is to understand whether small financial incentives and messaging can increase the take-up of COVID-19 boosters among patients empaneled at a county public health system. The motivation for this work is the relatively low take-up of COVID-19 boosters. In California, where our experiment is based, only 59% of the population has been boosted, with only 13% receiving the recommended bivalent booster (State of California, 2022).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
57,893 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Rajiv Pramanik, MD; Mireille Jacobson, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal